Genetic Signatures (ASX:GSS) FCF Margin %: -10.92% (As of Dec. 2025)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Genetic Signatures FCF Margin %?

Genetic Signatures ASX:GSS -1.49% FCF Margin % is -10.92% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Genetic Signatures ranks worse than 79.8% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Genetic Signatures's Free Cash Flow for the six months ended in Dec. 2025 was A$-0.95 Mil. Genetic Signatures's Revenue for the six months ended in Dec. 2025 was A$8.68 Mil. Therefore, Genetic Signatures's FCF Margin % for the quarter that ended in Dec. 2025 was -10.92%.

As of today, Genetic Signatures's current FCF Yield % is -71.17%.

The historical rank and industry rank for Genetic Signatures's FCF Margin % or its related term are showing as below:

ASX:GSS' s FCF Margin % Range Over the Past 10 Years
Min: -175.86 Med: -100.67 Max: 19.25
Current: -66.34

During the past 11 years, the highest FCF Margin % of Genetic Signatures was 19.25%. The lowest was -175.86%. And the median was -100.67%.

ASX:GSS's FCF Margin % is ranked worse than
79.8% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.8 vs ASX:GSS: -66.34

Genetic Signatures FCF Margin % Related Terms

Genetic Signatures FCF Margin % Historical Data

* Premium members only.

The historical data trend for Genetic Signatures's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Signatures FCF Margin % Chart

Genetic Signatures Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

FCF Margin %

Get a 7-Day Free Trial

-2.77

19.25

-96.18

-152.68

-82.96

Genetic Signatures Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
FCF Margin %	Get a 7-Day Free Trial															-158.13	-149.50	-40.83	-131.35	-10.92

ASX:GSS vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Genetic Signatures's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Signatures FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's FCF Margin % falls into.

Save Embed

Genetic Signatures FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Genetic Signatures's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2025 )	/	Revenue (A: Jun. 2025 )
	=	-13.191	/	15.9
	=	-82.96 %

Genetic Signatures's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	-0.948	/	8.681
	=	-10.92 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -10.92% mean?

Genetic Signatures (ASX:GSS) has a FCF Margin % of -10.92% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genetic Signatures and its competitors. According to the industry distribution chart, Genetic Signatures ranks #162 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 79.8%.

Is Genetic Signatures' FCF Margin % too high?

Genetic Signatures' current FCF Margin % is -10.92%. Based on the distribution chart, Genetic Signatures ranks #162 out of 203 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.

How does Genetic Signatures' FCF Margin % compare to TMO and DHR?

According to the Medical Diagnostics & Research industry distribution chart, Genetic Signatures ranks #162 out of 203 companies for FCF Margin %. This places Genetic Signatures in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Medical Diagnostics & Research company?

A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Genetic Signatures and its competitors. Genetic Signatures's current FCF Margin % is -10.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Genetic Signatures stock overvalued right now?

Based on GuruFocus' analysis, Genetic Signatures (ASX:GSS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.38, compared to a current price of A$0.07 — trading 82.6% below its estimated fair value. The current FCF Margin % is -10.92%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Genetic Signatures (ASX:GSS), the current FCF Margin % is -10.92% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genetic Signatures Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies ASX:IME ASX:IBX ASX:MAP ASX:BDX ASX:RHY ASX:CTE TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH

Address 7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website https://www.geneticsignatures.com

Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.